GSK reports positive RSV vaccine data
![Photo: Hannah Mckay/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14130195.ece/ALTERNATES/schema-16_9/20220427-083317-3-5433x3053ma.jpg)
GSK, formerly Glaxosmithkline, has reported positive data from its RSV vaccine trial, Bloomberg News reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
RSV caused more than 100,000 child mortalities in 2019
For subscribers
Pfizer to acquire Reviral as RSV race continues
For subscribers